Capitol Health Provided Update Regarding Additional MRI Medicare License Process

Stethoscope with financial on the desk.

Capitol Health Ltd (ASX: CAJ) is mainly involved in the operations of providing imaging services in Australian Healthcare market. On 5 October 2018, the company provided an update regarding the Federal Government’s recent announcement about the pending allocation of 20 new Medicare MRI licenses, comprising a mix of fully eligible units and upgrades of existing partial units. Following this news, the share price of the company decreased by 1.818 percent as on 5 October 2018.

The Australian Prime Minister and the Minister for Health announced that there will be an increase in patient access to Medicare-funded MRI services and Twenty new licenses will be issued shortly through an invitation to apply process and these new licenses will have access to Medicare funding from as early as 1 March 2019. Capitol is planning to submit its applications for the number of new licenses.

Capitol is currently operating clinics across Victoria, Western Australia, and Tasmania. And, the company currently has a fleet of 18 MRIs which includes one under installation and two are having full Medicare licenses, eight have partial Medicare licenses, and eight do not have Medicare licenses and they operate without attracting a Medicare rebate. The Company has several sites suitable for Medicare-funded MRI services and it is expected that the allocation process will support the Capitol’s commitment to providing bulk-billed MRI services in communities that need them. [optin-monster-shortcode id=”wxhmli4jjedneglg1trq”]

In advance of this process, Capitol has been advised that the partial MRI Medicare license which was previously transferred to Mildura will transfer back to Imaging at Olympic Park from March 2019 and the full MRI Medicare license which was transferred to Imaging at Olympic Park in December 2016 will revert to Mildura to coincide with the commencement of newly-allocated MRI licenses. The company will try to retain the full license at Imaging at Olympic Park through the recently-announced MRI licensing program by applying for an upgrade to its existing partial license and it is expecting that this valuable service to Melbourne’s CBD will be retained after the allocation process is complete. The company has concluded that the impact of the potential reversion to a partial license and the potential timing will not have any significant impact in FY 2019 and confirms its earnings guidance range.

CAJ’s shares traded at $0.270 with a market capitalization of circa $220.48 million as on 5 October 2018 (AEST 2:18 PM).

Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


Disclaimer

The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.


6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report